Literature DB >> 31209039

Morphine tolerance is attenuated in germfree mice and reversed by probiotics, implicating the role of gut microbiome.

Li Zhang1,2, Jingjing Meng2, Yuguang Ban3, Richa Jalodia2, Irina Chupikova2, Irina Fernandez4, Nivis Brito4, Umakant Sharma2, Maria T Abreu4, Sundaram Ramakrishnan2, Sabita Roy5.   

Abstract

Prolonged exposure to opioids results in analgesic tolerance, drug overdose, and death. The mechanism underlying morphine analgesic tolerance still remains unresolved. We show that morphine analgesic tolerance was significantly attenuated in germfree (GF) and in pan-antibiotic-treated mice. Reconstitution of GF mice with naïve fecal microbiota reinstated morphine analgesic tolerance. We further demonstrated that tolerance was associated with microbial dysbiosis with selective depletion in Bifidobacteria and Lactobacillaeae. Probiotics, enriched with these bacterial communities, attenuated analgesic tolerance in morphine-treated mice. These results suggest that probiotic therapy during morphine administration may be a promising, safe, and inexpensive treatment to prolong morphine's efficacy and attenuate analgesic tolerance. We hypothesize a vicious cycle of chronic morphine tolerance: morphine-induced gut dysbiosis leads to gut barrier disruption and bacterial translocation, initiating local gut inflammation through TLR2/4 activation, resulting in the activation of proinflammatory cytokines, which drives morphine tolerance.

Entities:  

Keywords:  germfree mice; gut dysbiosis; gut−immune−brain axis; morphine tolerance

Mesh:

Substances:

Year:  2019        PMID: 31209039      PMCID: PMC6613141          DOI: 10.1073/pnas.1901182116

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

Review 1.  Strategies to manage the adverse effects of oral morphine: an evidence-based report.

Authors:  N Cherny; C Ripamonti; J Pereira; C Davis; M Fallon; H McQuay; S Mercadante; G Pasternak; V Ventafridda
Journal:  J Clin Oncol       Date:  2001-05-01       Impact factor: 44.544

Review 2.  Opioids: cellular mechanisms of tolerance and physical dependence.

Authors:  Chris P Bailey; Mark Connor
Journal:  Curr Opin Pharmacol       Date:  2005-02       Impact factor: 5.547

3.  The involvement of glial cells in the development of morphine tolerance.

Authors:  P Song; Z Q Zhao
Journal:  Neurosci Res       Date:  2001-03       Impact factor: 3.304

4.  Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study.

Authors:  W Ma; W H Zheng; K Powell; K Jhamandas; R Quirion
Journal:  Eur J Neurosci       Date:  2001-10       Impact factor: 3.386

5.  Interleukin-1 antagonizes morphine analgesia and underlies morphine tolerance.

Authors:  Yehuda Shavit; Gilly Wolf; Inbal Goshen; Dina Livshits; Raz Yirmiya
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

6.  The role of spinal neuroimmune activation in morphine tolerance/hyperalgesia in neuropathic and sham-operated rats.

Authors:  Vasudeva Raghavendra; Maria D Rutkowski; Joyce A DeLeo
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

7.  Inhibition of neuronal nitric oxide synthase antagonizes morphine antinociceptive tolerance by decreasing activation of p38 MAPK in the spinal microglia.

Authors:  Wei Liu; Chu-Huai Wang; Yu Cui; Li-Qiu Mo; Jun-Li Zhi; Sheng-Nan Sun; Yan-Li Wang; Hui-Min Yu; Chun-Mei Zhao; Jian-Qiang Feng; Pei-Xi Chen
Journal:  Neurosci Lett       Date:  2006-11-13       Impact factor: 3.046

8.  Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors.

Authors:  Christel Rousseaux; Xavier Thuru; Agathe Gelot; Nicolas Barnich; Christel Neut; Laurent Dubuquoy; Caroline Dubuquoy; Emilie Merour; Karen Geboes; Mathias Chamaillard; Arthur Ouwehand; Greg Leyer; Didier Carcano; Jean-Frédéric Colombel; Denis Ardid; Pierre Desreumaux
Journal:  Nat Med       Date:  2006-12-10       Impact factor: 53.440

9.  A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine.

Authors:  Ian N Johnston; Erin D Milligan; Julie Wieseler-Frank; Matthew G Frank; Varlin Zapata; Jay Campisi; Stephen Langer; David Martin; Paula Green; M Fleshner; Leslie Leinwand; Steven F Maier; Linda R Watkins
Journal:  J Neurosci       Date:  2004-08-18       Impact factor: 6.167

Review 10.  Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia.

Authors:  Joyce A DeLeo; Flobert Y Tanga; Vivianne L Tawfik
Journal:  Neuroscientist       Date:  2004-02       Impact factor: 7.519

View more
  21 in total

Review 1.  The "Culture" of Pain Control: A Review of Opioid-Induced Dysbiosis (OID) in Antinociceptive Tolerance.

Authors:  Ryan A Mischel; Karan H Muchhala; William L Dewey; Hamid I Akbarali
Journal:  J Pain       Date:  2019-12-11       Impact factor: 5.820

2.  Evidence for Modulation of Substance Use Disorders by the Gut Microbiome: Hidden in Plain Sight.

Authors:  Mariana Angoa-Pérez; Donald M Kuhn
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

3.  The Guts of the Opioid Crisis.

Authors:  Karan H Muchhala; Joanna C Jacob; Minho Kang; William L Dewey; Hamid I Akbarali
Journal:  Physiology (Bethesda)       Date:  2021-09-01

4.  Opioid Use in Murine Model Results in Severe Gastric Pathology that May Be Attenuated by Proton Pump Inhibition.

Authors:  Nillu Ghosh; Kousik Kesh; Sundaram Ramakrishnan; Sabita Roy
Journal:  Am J Pathol       Date:  2022-05-20       Impact factor: 5.770

Review 5.  Prenatal opioid exposure and vulnerability to future substance use disorders in offspring.

Authors:  Yaa Abu; Sabita Roy
Journal:  Exp Neurol       Date:  2021-01-29       Impact factor: 5.330

6.  Role of β-arrestin-2 in short- and long-term opioid tolerance in the dorsal root ganglia.

Authors:  Karan H Muchhala; Joanna C Jacob; William L Dewey; Hamid I Akbarali
Journal:  Eur J Pharmacol       Date:  2021-03-08       Impact factor: 4.432

7.  Gut permeability and cognitive decline: A pilot investigation in the Northern Manhattan Study.

Authors:  Tatjana Rundek; Sabita Roy; Mady Hornig; Ying Kuen Cheung; Hannah Gardener; Janet DeRosa; Bonnie Levin; Clinton B Wright; Victor J Del Brutto; Mitchell Sv Elkind; Ralph L Sacco
Journal:  Brain Behav Immun Health       Date:  2021-01-29

Review 8.  Contributions of neuroimmune and gut-brain signaling to vulnerability of developing substance use disorders.

Authors:  Kelsey E Lucerne; Aya Osman; Katherine R Meckel; Drew D Kiraly
Journal:  Neuropharmacology       Date:  2021-05-06       Impact factor: 5.273

9.  Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity.

Authors:  Angélica Cruz-Lebrón; Ramona Johnson; Claire Mazahery; Zach Troyer; Samira Joussef-Piña; Miguel E Quiñones-Mateu; Christopher M Strauch; Stanley L Hazen; Alan D Levine
Journal:  Gut Microbes       Date:  2021 Jan-Dec

10.  Fecal microbiota transplantation and antibiotic treatment attenuate naloxone-precipitated opioid withdrawal in morphine-dependent mice.

Authors:  Ana C Thomaz; Vishakh Iyer; Taylor J Woodward; Andrea G Hohmann
Journal:  Exp Neurol       Date:  2021-06-18       Impact factor: 5.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.